Hemokonsentrasi dan Trombositopenia pada COVID-19, Pembelajaran dari Ruang Instalasi Gawat Darurat

Dani Rosdiana, Marlina Tasril, M Firdaus J Karimi

Abstract

Coronavirus disease 2019 (COVID-19) has become a pandemic since January 2020 and caused the death of 6 million people by April 2022. Exponential human-to-human transmission and the wide variety of clinical and laboratory manifestations of COVID-19 were challenging. Hematological abnormalities such as thrombocytopenia and hemoconcentration in COVID-19 are difficult to distinguish from dengue fever in the ER. Misdiagnosis would impact patient outcomes, health workers, and community safety as well as its transmission. We report a suspected case of dengue fever in admission in X Pekanbaru hospital, Riau which is confirmed as COVID-19. The patient was observed in the isolation ward and treated accordingly to the COVID-19 protocol and heparin due to coagulopathy related to COVID-19. The Proper initial assessment of acute febrile, especially Dengue fever at the emergency room, and the availability of modalities in diagnosing COVID-19 are of paramount importance in the era of the COVID-19 pandemic, even more, it become endemic status.

Keywords

coagulopathy, COVID-19, hemoconcentration, thrombocytopenia

References

Sofi MS, Hamid A, Bhat SU. SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment. Vol. 2, Biosafety and Health. Elsevier B.V.; 2020. p. 217–25.

da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, Farias de Oliveira T, Campos Alcântara R, Monteiro Arnozo G, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Vol. 133, Wiener Klinische Wochenschrift. Springer; 2021. p. 377–82.

Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review [Internet]. Vol. 13, Journal of Infection and Public Health. Elsevier Ltd; 2020 [cited 2022 May 11]. p. 667–73. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142680/

Allam MF. Scoring System for the Diagnosis of COVID-19. Open Public Health J [Internet]. 2020;13(1):413–4. Available from: https://openpublichealthjournal.com/contents/volumes/V13/TOPHJ-13-413/TOPHJ-13-413.pdf

Wong CKH, Wong JYH, Tang EHM, Au CH, Wai AKC. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Rep [Internet]. 2020;10(1):1–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666204/pdf/41598_2020_Article_74988.pdf

Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Vol. 55, European Respiratory Journal. European Respiratory Society; 2020.

Chatterjee SK, Saha S, Munoz MNM, Piccaluga PP. Molecular Pathogenesis , Immunopathogenesis and Novel Therapeutic Strategy Against. 2020;7(August):1–11.

Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and Anosmia: A review based on up-to-date knowledge. WwwElsevierCom/Locate/Amjoto [Internet]. 2020;41(January):1–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265845/pdf/main.pdf

Tang KF, Ooi EE. Diagnosis of dengue: An update. Expert Rev Anti Infect Ther. 2012;10(8):895–907.

Nasomsong W, Luvira V, Phiboonbanakit D. Case report: dengue and COVID-19 coinfection in Thailand. Am J Trop Med Hyg. 2021;104(2):487–9.

Yan G, Lee CK, Lam L, Lim A. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet. 2020;(January):19–20.

Henrina J, Putra ICS, Lawrensia S, Handoyono QF, Cahyadi A. Coronavirus disease of 2019: a mimicker of dengue infection? SN Compr Clin Med. 2020;2(8):1109–19.

Datta M, Ferdousi A, Ahmed FU, Barua D, Biswas S, Amin J Bin, et al. Assessment of Platelet Count in Pediatric Patients with Dengue Fever Admitted in A Tertiary Care Hospital of Bangladesh. IAHS Med J. 2022;4(1):13–6.

Asghar M, Hussain N, Shoaib H, Kim M, Lynch TJ. Hematological characteristics of patients in coronavirus 19 infection: a systematic review and meta-analysis. J Community Hosp Intern Med Perspect [Internet]. 2020;10(6):508–13. Available from: https://doi.org/10.1080/20009666.2020.1808360

Liu H, Wang Z, Sun H, Teng T, Li Y, Zhou X, et al. Thrombosis and coagulopathy in COVID-19: current understanding and implications for antithrombotic treatment in patients treated with percutaneous coronary intervention. Front Cardiovasc Med. 2021;7(January):1–10.

Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S. A systematic review of asymptomatic infections. J Microbiol Immunol Infect [Internet]. 2020;51(1):12–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227597/pdf/main.pdf

Wong C, Lam H, Ho-Tung Fong, Ambrose Ting Leung S, Wing-Yan Chin, Thomas, Shing Yen Lo C, Mei-Sze Lui M, Chun Yin Lee J, et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology [Internet]. 2020;xxx. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233401/

Tang Y, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: Current Issues and Challanges. J Clin Microbiol. 2020;58(6):1–9.

Lythgoe MP, Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Cell Press Rev. 2020;14(January).

DOI: https://doi.org/10.26891/JIK.v17i1.2023.84-89

Refbacks

  • There are currently no refbacks.